Could SARS-CoV-2 herald a surge of multiple sclerosis?

被引：3

作者：

Shalaby, Nevin Mohieldin ^{[1
]}

Shehata, Hatem Samir ^{[1
]}

机构：

[1] Cairo Univ, Kasr Al Ainy Sch Med, Dept Neurol, Dept 15,Second Floor,Al Saraya St, Cairo, Egypt

来源：

EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY | 2021年 / 57卷 / 01期

关键词：

COVID-19; SARS-CoV-2; Multiple sclerosis; Neurotropism;

D O I：

10.1186/s41983-021-00277-5

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

During the current COVID-19 pandemic, many queries are raised regarding its nature, outcome, and sequelae. This letter raises the concern of potential impact on increasing the incidence of multiple sclerosis whose pathology involves a possible viral etiology. Besides, the potential neurotropism of the acute respiratory distress syndrome corona virus-2 (SARS-CoV-2), which is still not established, may raise concerns about the use of certain disease modifying therapies namely natalizumab.

引用

页数：2